Pulmonx Corporation
LUNGNASDAQHealthcare● Active
$1.50
+$0.01(+0.67%)
Market Cap$63355800
P/E Ratio—
52W High$3.88
52W Low$1.13
Pulmonx Corporation（LUNG）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LUNG · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $90.50M | $83.79M | $68.67M | $53.66M | $48.42M |
| Cost of Revenue | $23.36M | $21.79M | $17.92M | $13.80M | $12.79M |
| Gross Profit | $67.14M | $62.00M | $50.75M | $39.87M | $35.63M |
| Gross Margin %(computed) | 74.19% | 74.00% | 73.90% | 74.29% | 73.59% |
| Operating Expenses | |||||
| R&D Expenses | $19.49M | $17.57M | $18.08M | $15.40M | $13.06M |
| G&A Expenses | $0.00M | $94.23M | $89.81M | $0.00M | $0.00M |
| Total Operating Expenses | $120.80M | $119.70M | $112.69M | $98.50M | $82.93M |
| Operating Income | ($53.66M) | ($57.70M) | ($61.94M) | ($58.64M) | ($47.30M) |
| Operating Margin %(computed) | -59.30% | -68.87% | -90.19% | -109.27% | -97.70% |
| Interest Income | $2.65M | $5.06M | $5.57M | $1.53M | $0.40M |
| Interest Expense | $3.15M | $3.51M | $3.23M | $1.07M | $0.83M |
| Income Before Tax | ($53.38M) | ($55.89M) | ($60.27M) | ($58.57M) | ($48.32M) |
| Income Tax Expense | $0.63M | $0.50M | $0.57M | $0.35M | $0.34M |
| Net Income | ($54.00M) | ($56.39M) | ($60.84M) | ($58.92M) | ($48.66M) |
| Net Margin %(computed) | -59.67% | -67.30% | -88.60% | -109.80% | -100.51% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 |
| Wtd Avg Shares | 40.69M | 39.11M | 37.97M | 37.10M | 36.13M |
| EBITDA | ($52.61M) | ($50.79M) | ($55.09M) | ($55.99M) | ($46.62M) |
| EBITDA Margin %(computed) | -58.13% | -60.62% | -80.22% | -104.34% | -96.29% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Pulmonx Corporation
关于Pulmonx Corporation（LUNG）损益表
Pulmonx Corporation（LUNG）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LUNG实现营收$0.09B，毛利润$0.07B（毛利率74.19%），净利润($0.05B)（净利率-59.67%）。
常见问题
LUNG · 4 问Pulmonx Corporation（LUNG）2025财年营收为$0.09B，同比up8.0%。
LUNG revenueLUNG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09